Implications of an Improved Model of the TSH Receptor Transmembrane Domain (TSHR-TMD-TRIO).


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 12 01 2021
pubmed: 12 3 2021
medline: 8 10 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

The thyroid-stimulating hormone receptor (TSHR) is a G-protein-coupled receptor group A family member with 7 transmembrane helices. We generated 3 new models of its entire transmembrane region using a 600 ns molecular simulation. The simulation started from our previously published model, which we have now revised by also modeling the intracellular loops and the C-terminal tail, adding internal waters and embedding it into a lipid bilayer with a water layer and with ions added to complete the system. We have named this model TSHR-TMD-TRIO since 3 representative dominant structures were then extracted from the simulation trajectory and compared with the original model. These structures each showed small but significant changes in the relative positions of the helices. The 3 models were also used as targets to dock a set of small molecules that are known active compounds including a new TSHR antagonist (BT362), which confirmed the appropriateness of the model with some small molecules showing significant preference for one or other of the structures.

Identifiants

pubmed: 33693584
pii: 6161546
doi: 10.1210/endocr/bqab051
pmc: PMC8183494
pii:
doi:

Substances chimiques

Receptors, Thyrotropin 0
Thyrotropin 9002-71-5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BLRD VA
ID : I01 BX000800
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK069713
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Endocrinol Metab Clin North Am. 2009 Jun;38(2):319-41, viii
pubmed: 19328414
J Mol Graph Model. 2003 Mar;21(5):463-72
pubmed: 12543141
Endocr Rev. 2016 Apr;37(2):114-34
pubmed: 26799472
Auto Immun Highlights. 2017 Dec;8(1):2
pubmed: 27921237
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
Nature. 1992 Mar 5;356(6364):83-5
pubmed: 1538787
Nat Chem Biol. 2012 Jul 18;8(8):670-3
pubmed: 22810761
Protein Eng. 2000 Sep;13(9):603-6
pubmed: 11054453
Front Endocrinol (Lausanne). 2020 Jun 26;11:372
pubmed: 32676053
Proteins. 2001;Suppl 5:92-7
pubmed: 11835486
Thyroid. 2005 Jul;15(7):746-7
pubmed: 16178067
J Chem Theory Comput. 2006 Sep;2(5):1429-34
pubmed: 26626850
Protein Eng Des Sel. 2008 Dec;21(12):729-35
pubmed: 18957407
Biopolymers. 2013 Mar;99(3):165-7
pubmed: 23280389
J Mol Endocrinol. 2011 Feb 15;46(2):81-99
pubmed: 21247981
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:51-71
pubmed: 31348870
FASEB J. 2008 Aug;22(8):2798-808
pubmed: 18381815
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Nat Rev Dis Primers. 2020 Jul 2;6(1):52
pubmed: 32616746
Thyroid. 2019 Jan;29(1):111-123
pubmed: 30351237
Science. 2007 Nov 23;318(5854):1266-73
pubmed: 17962519
Thyroid. 2007 May;17(5):395-410
pubmed: 17542669
J Am Chem Soc. 1972 Nov 15;94(23):8205-12
pubmed: 5079964
Nucleic Acids Res. 2012 Jan;40(Database issue):D71-5
pubmed: 22102590
Acta Pharmacol Sin. 2012 Mar;33(3):289-90
pubmed: 22388110
Crit Rev Ther Drug Carrier Syst. 1997;14(1):1-104
pubmed: 9043816
Front Endocrinol (Lausanne). 2016 Sep 27;7:130
pubmed: 27729899
Thyroid. 2015 Jan;25(1):51-62
pubmed: 25333622
J Comput Chem. 2010 Nov 15;31(14):2658-68
pubmed: 20740566
J Biomol Struct Dyn. 2015;33(5):1140-52
pubmed: 25012978
Endocrinology. 2014 Jan;155(1):310-4
pubmed: 24169564

Auteurs

Mihaly Mezei (M)

Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Rauf Latif (R)

Thyroid Research Unit, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
James J. Peters VA Medical Center, New York, NY, USA.

Bhaskar Das (B)

Arnold & Marie Schwartz College of Pharmacy & Health Sciences, Long Island University, New York, NY, USA.

Terry F Davies (TF)

Thyroid Research Unit, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
James J. Peters VA Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH